Retroviral Restriction Factors TRIM5: Therapeutic Strategy to Inhibit HIV-1 Replication

E-ISSN： 1875-533x|18|17|2649-2654

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.18, Iss.17, 2011-06, pp. : 2649-2654

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Viral Infectivity Factor: A Novel Therapeutic Strategy to Block HIV-1 Replication

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 7, 2013-06 ,pp. : 1047-1055

Bentham Science Publishers

Access to resources Recommend Favorite

Restriction of retroviruses by TRIM5α

By Towers Greg

Future Virology, Vol. 1, Iss. 1, 2006-01 ,pp. : 71-78

Future Medicine

Access to resources Recommend Favorite

New Therapeutic Approaches Targeted at the Late Stages of the HIV-1 Replication Cycle

Current Medicinal Chemistry, Vol. 18, Iss. 1, 2011-01 ,pp. : 16-28

Bentham Science Publishers

Access to resources Recommend Favorite

Proteolytic Events of HIV-1 Replication as Targets for Therapeutic Intervention

Current Pharmaceutical Design, Vol. 9, Iss. 22, 2003-08 ,pp. : 1803-1815

Bentham Science Publishers

Access to resources Recommend Favorite

Cellular HIV-1 restriction factors: a new avenue for AIDS therapy?

By Barr Stephen D

Future Virology, Vol. 5, Iss. 4, 2010-07 ,pp. : 417-433

Future Medicine

Access to resources Recommend Favorite